Effect of Therapeutic Class on Generic Drug Substitutions (U01)
The purpose of this study is to rank order generic drugs based on therapeutic class with low generic substitution/acceptance rate and analyze factors affecting the generic substitution in each therapeutic class. The outcome of this study will help identify research needs and align FDAÂ’s regulatory science efforts to monitor and ensure successful generic substitution and thereby assure the public about generic drug safety and efficacy.
General information about this opportunity
Last Known Status
Deleted 07/21/2014 (Archived.)
Program Number
RFA-FD-14-014 Federal Agency/Office
Agency: Department of Health and Human ServicesOffice: Food and Drug Administration
Type(s) of Assistance Offered
Cooperative Agreement Number of Awards Available
2 Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
FOREIGN INSTITUTIONS ARE ELIGIBLE TO APPLY What is the process for applying and being award this assistance?
Deadlines
06/21/2014 Other Assistance Considerations
Formula and Matching Requirements
This program does not have cost sharing or matching requirements. Who do I contact about this opportunity?
Headquarters Office
Martin BernardGrants Management Specialist
Phone 240-402-7564
Website Address
http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-14-014.html
E-mail Address
Martin.Bernard@fda.hhs.gov
Financial Information
Obligations
$400,000.00 Range and Average of Financial Assistance
Awards range from $350,000.00 to $400,000.00
